To clarify Azer-cel on so called clinicaltrials.gov , I have...

To clarify Azer-cel on so called clinicaltrials.gov , I have received clarification from CFO Mike to share with share holder that apparently it's typos on the site.

We were aware of the typos on clinicaltrials.gov and have made the changes.
The estimated primary date and two years (720 days) following will be noted as the study completion, however this is the patient follow up period and not the data for registrational/pivotal study. The data will be from the estimated primary date.
The 28 days was an artifact from the previous Precision Biosciences study for dose escalation


Quote: